Next Generation News and Research

RSS

Jivan Biologics awarded US patent for splice array analysis

Jivan Biologics Inc., a privately held corporation located in Berkeley, CA, has been awarded US Patent #7,340,349, "Method and System for Identifying Splice Variants of a Gene."

10 Mar 2008

Watery pools in bone marrow key to psoriatic arthritic damage

Researchers have learned more about how a leading drug prevents certain types of arthritis from eating away at bone, according to a study published in the March edition of the Annals of the Rheumatic Diseases.

4 Mar 2008

Researchers working to curb impulsivity in children with ADHD

Central Michigan University researchers are one step closer to helping children with attention deficit/hyperactivity disorder improve their self-control.

4 Mar 2008

New global study of targeted therapies for breast cancer

Two targeted medications designed to treat an aggressive form of breast cancer are being tested in a new study involving 8,000 participants in 50 countries across six continents -- a clinical trial that investigators hope will provide a new model for global cancer research.

1 Mar 2008

Tenofovir gel safe for daily use over an extended period

A vaginal microbicide that incorporates an antiretroviral (ARV) drug normally used to treat people with HIV is safe for sexually active HIV-negative women to use every day over an extended period, suggest results of a clinical trial of tenofovir topical gel.

27 Feb 2008

PolyTherics and Celtic Pharma sign agreement to explore technologies for improved drug performance

PolyTherics Limited, a biopharmaceutical spin-out company from Imperial College London and the London School of Pharmacy, and Celtic Pharma Development Services Bermuda Ltd, a subsidiary of Celtic Pharmaceutical Holdings LP, a global private equity investment fund focused on the biopharma industry, today announced that they have entered into a broad research collaboration agreement.

26 Feb 2008

Genomatix integrates genome-wide open chromatin from next generation sequencing

Genomatix Software GmbH, a Systems Biology company focussed on high quality annotation and the understanding of gene regulation, has begun showcasing its abilities in the analysis of data generated by Next Generation Sequencing (NGS) technology.

26 Feb 2008

Experimental anti-HIV gel is safe for women to use on a daily basis

An experimental anti-HIV gel is safe for women to use on a daily basis, according to researchers at the University of Alabama at Birmingham (UAB) and the University of Pittsburgh School of Medicine.

26 Feb 2008

Thomson Healthcare announces new application portal

Thomson Healthcare has announced the next generation of its decision support tool, Medstat Advantage Suite 4.0(R), based on the leading technology platform in business intelligence.

21 Feb 2008

Bacterial toxin closes gate on immune response

Researchers at the University of Pennsylvania School of Medicine have demonstrated that a bacterial toxin from the common bacterium Staphylococcus aureus shuts down the control mechanism of the tunnel, called an ion channel, in immune cell membranes.

14 Feb 2008

New Centre to be at the heart of UK’s cardiovascular research

Expertise from across the University of Leeds is to be channelled into a new research centre that aims to progress the understanding, treatment and prevention of cardiovascular diseases.

13 Feb 2008

What gives us fingertip dexterity?

Quickly moving your fingertips to tap or press a surface is essential for everyday life to, say, pick up small objects, use a BlackBerry or an iPhone.

8 Feb 2008

Gene expression in meningiomas may vary by hormone receptor status

An association between hormones and meningioma has long been postulated, but the specific nature of this relationship has remained unclear.

4 Feb 2008

New target for flu prevention

Emerging subtypes of influenza A virus hold the potential to initiate a world-wide epidemic in the next few years, according to World Health Organization officials.

4 Feb 2008

Weakness found in anthrax bacterium

MIT and New York University researchers have identified a weakness in the defenses of the anthrax bacterium that could be exploited to produce new antibiotics.

25 Jan 2008

JDSU advances the world of polarization optics

JDSU is advancing the world of polarization optics with today's announcement of its ability to combine thin-film and liquid crystal polymer technologies to produce high-quality custom birefringent components.

22 Jan 2008

Genmab reaches milestones in Ofatumumab collaboration

The second milestone payment of the collaboration of DKK 87.2 million was triggered by treatment of the first patient in the Phase II study of ofatumumab in Diffuse Large B-Cell Lymphoma (DLBCL), which occurred in 2007.

22 Jan 2008

Should children be tested for gene mutations linked to cancers?

It's an ethical dilemma with serious implications. Should children be tested for gene mutations that predispose them to developing breast cancer and/or ovarian cancer later in life?

16 Jan 2008

Biotechnology Industry Organization supports FDA's safety conclusions on animal cloning

Biotechnology Industry Organization (BIO) President and Chief Executive Officer Jim Greenwood today issued the following statement in response to a risk assessment published today by the U.S. Food and Drug Administration (FDA) regarding the safety of milk and meat products from cloned animals and their offspring:

15 Jan 2008

Study finds most psychiatric patients have more than one diagnosis

A new study by Rhode Island Hospital researchers reports that the majority of 2,300 psychiatry outpatients had more than one disorder when seeking treatment, and more than one-third had at least three disorders.

15 Jan 2008